Dr Yen Tai is a consultant neurologist and honorary Clinical Senior Lecturer with special interests in the study and treatment of movement disorders. He has a research background in using functional imaging to study the pathogenesis and treatment responses of neuroprotective therapy in neurodegenerative diseases, in particular Parkinson's and Huntington's diseases. More recently, he is also interested in using technology and neuromodulation, including deep brain stimulation, to improve the treatment of movement disorders.
et al., 2020, Clinical and Dopamine Transporter Imaging Characteristics of Leucine- Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross-Sectional Study, Movement Disorders, ISSN:0885-3185
et al., 2020, A heterogeneous sensing suite for multisymptom quantification of Parkinson’s disease, Ieee Transactions on Neural Systems and Rehabilitation Engineering, ISSN:1534-4320
et al., 2020, Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study, Lancet Neurology, Vol:19, ISSN:1474-4422, Pages:71-80
et al., 2019, Predicting progression in Parkinson's Disease using baseline and 1-Year change measures, Journal of Parkinsons Disease, Vol:9, ISSN:1877-718X, Pages:665-679
et al., 2019, Traditional trial-and-error versus neuroanatomical-3D-image software-assisted deep brain stimulation programming in patients with Parkinson's disease, World Neurosurgery, Vol:134, ISSN:1878-8750, Pages:e98-e102